Vascular and hypertensive conditions – including hypertension, acute coronary syndrome, and stroke – represent critical cardiovascular challenges requiring sophisticated management strategies. As antihypertensive agents evolve and vascular intervention approaches advance, real-world evidence is essential to understand contemporary clinical practice, reveal persistent management barriers, and enable development of transformative vascular therapies.
Adelphi Real World’s Disease Specific Programmes (DSPs) are designed to address these needs.
Our DSPs generate comprehensive real-world data reflecting vascular disease complexity. Through engagement with vascular specialists and patient populations, we provide essential insights on:
Blood Pressure Management & Control Strategies
Examine hypertension detection practices, treatment initiation decisions, drug sequencing approaches, and control achievement across diverse clinical settings and patient demographics.
Acute Vascular Event Management & Prevention
Explore acute coronary syndrome and stroke management protocols, intervention approaches, secondary prevention strategies, and real-world clinical outcomes.
Treatment Adherence & Long-Term Outcomes
Understand patient persistence with therapy, medication compliance factors, cardiovascular event rates, and quality of life trajectory in vascular disease populations.
Management Challenges & Innovation Opportunities
Identify barriers to optimal blood pressure control, unmet prevention needs, and pathways for developing novel vascular protective therapies.
Vascular & Hypertensive Disorder Disease Specific Programmes (DSPs) Portfolio
Why Choose Adelphi Real World?
Vascular Disease Expertise
Specialised knowledge of hypertensive and vascular pathophysiology with rigorous research standards.
Patient-Informed Evidence
Genuine patient perspectives shape clinically meaningful research outcomes.
Global Market Insights
Cross-country analysis enabling understanding of regional vascular management approaches.
Strategic Commercial Support
Evidence informing clinical strategy, payer engagement, and market access decisions.
Current Countries Vascular & Hypertensive Disorder DSPs Cover
Our Partnership Framework
We work with pharmaceutical developers, vascular centres, primary and secondary care networks, patient advocacy organisations, and healthcare authorities to generate evidence advancing vascular disease understanding and accelerating treatment innovation.
Explore Our Vascular & Hypertensive Expertise
- Schedule a Strategic Discussion: Connect with our vascular specialists to explore how real-world evidence can enhance your hypertension and vascular disease programmes.
- Request Customised Resources: Interested in our research capabilities, international scope, or specific clinical applications? Contact our team for tailored information.
Strengthen your vascular and hypertensive disease research with Adelphi Real World’s integrated DSP solutions. Let’s collaborate to deepen clinical understanding, drive therapeutic innovation, and ultimately improve outcomes for vascular disease patients.
Contact us today using the form below.
Heart Rhythm & Structural Disorders DSPs
Conferences Attending
Other Services